SAN
DIEGO, Jan. 9, 2025 /PRNewswire/ -- Illumina,
Inc. (NASDAQ:ILMN) announced today that it will issue results for
the fourth quarter and full year 2024 following the close of market
on Thursday, February 6,
2025.
On the same day, at 1:30 pm Pacific
Time (4:30 pm Eastern Time)
Jacob Thaysen, PhD, Chief Executive
Officer, and Ankur Dhingra, Chief
Financial Officer, will host a conference call with analysts,
investors, and other interested parties to discuss financial and
operating results.
Conference Call Details
The conference call will begin at 1:30 pm
Pacific Time (4:30 pm Eastern
Time) on Thursday, February 6,
2025. Interested parties may access the live webcast via the
Investor Info section of Illumina's website or directly through the
following link -
https://illumina-earnings-call-q4-2024.open-exchange.net/. To
ensure timely connection, please join at least ten minutes before
the scheduled start of the call.
A replay of the conference call will be posted on
Illumina's website after the event and will be available for
at least 30 days following.
About Illumina
Illumina is improving human health by unlocking the power of the
genome. Our focus on innovation has established us as a global
leader in DNA sequencing and array-based technologies, serving
customers in the research, clinical, and applied markets. Our
products are used for applications in the life sciences, oncology,
reproductive health, agriculture, and other emerging segments. To
learn more, visit www.illumina.com and connect with us
on X
(Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube
Investors:
Salli Schwartz
+1.858.291.6421
ir@illumina.com
Media:
Bonny Fowler
+1.740.641.5579
pr@illumina.com
View original
content:https://www.prnewswire.com/news-releases/illumina-to-announce-fourth-quarter-and-full-year-2024-financial-results-on-thursday-february-6-2025-302347521.html
SOURCE Illumina, Inc.